# BOC & Utrust Private Equity Fund Management

> BOC & Utrust Private Equity Fund Management is a VC fund backing Health Care and Biotechnology. See 13 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Guangzhou, China
- Total investments: 13
- Last investment: Apr 2026
- Lead investor: 31%
- Last updated: Aug 2026
- Website: http://www.bocutrust.com/

BOC & Utrust Private Equity Fund Management is a private equity firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 31% |
| Biotechnology | 4 | 31% |
| Manufacturing | 4 | 31% |
| Pharmaceutical | 3 | 23% |
| Artificial Intelligence | 3 | 23% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 5 | 38% |
| Series B | 4 | 31% |
| Seed | 2 | 15% |
| Series A | 2 | 15% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 11 | 85% |
| Switzerland | 1 | 8% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Conmind Medical | Conmind Medical is a medical device company that provides safe, effective, and innovative neurointerventional and cardiac interventional medical devices. | $29.1M | Series C | Apr 07, 2026 |  |
| Shifeng Intelligent | Shifeng Intelligent Technology is a high-tech enterprise specializing in the manufacturing of intelligent equipment. |  | Seed | Feb 02, 2026 |  |
| Leman Biotech | Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies. | $28.8M | Series A | Jan 26, 2026 |  |
| Extreme Computing Technology | Extreme Computing Technology focuses on technology services such as artificial intelligence, the Internet of Things, and cloud computing. |  | Seed | Jan 19, 2026 |  |
| Zhilong New Materials | Zhilong New Materials is a Sino-foreign joint venture semiconductor material innovation enterprise that researches, produces, and sells semiconductor display sputtering targets and semiconductor photovoltaic targets. |  | Series A | Dec 31, 2024 |  |
| KingFocus Biomedical | Shenzhen based Biomedical Company. |  | Series C | Aug 28, 2024 |  |
| Sitan Technology | Sitan Technology is a technology enterprise specializing in the development, production, and sale of Micro-LED technology. |  | Series B | May 21, 2024 |  |
| Bostal Drug Delivery | Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems. The company provides pharmaceutical preparation technology platforms to develop innovative drugs, improve new drugs, and high-end generic drugs. It also offers preparation products technical development services for pharmaceutical companies.Thecompany was founded in 2013 and is headquartered in Guangzhou, Guangdong. |  | Series B | Aug 18, 2023 |  |
| ForChange | ForChange is an artificial intelligence online education company. |  | Series B | Apr 26, 2022 |  |
| Magpie Pharmaceuticals | Magpie Pharmaceuticals specialize in the research and development of first-in-class drugs. The company focuses on the structural modification and transformation of active natural product monomers in traditional Chinese medicines (TCM), as well as small molecular compounds currently in clinical use. | $14M | Series C | Apr 20, 2020 |  |

10 of 13 investments shown.

## Co-investors
- [Guangdong Technology Financial Group](https://shizune.co/investors/profile/guangdong-technology-financial-group) — VC Fund, 3 deals together
- [Zhongshan Venture Capital](https://shizune.co/investors/profile/zhongshan-venture-capital) — VC Fund, 3 deals together
- [BOCOM International](https://shizune.co/investors/profile/bocom-international) — VC Fund, 1 deal together
- [Canton Venture Capital](https://shizune.co/investors/profile/canton-venture-capital) — VC Fund, 1 deal together
- [CCB International](https://shizune.co/investors/profile/ccb-international) — VC Fund, 1 deal together
- [China Cinda Asset Management](https://shizune.co/investors/profile/china-cinda-asset-management) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does BOC & Utrust Private Equity Fund Management invest in?

BOC & Utrust Private Equity Fund Management invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series C and Series B stage. Most of the 13 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did BOC & Utrust Private Equity Fund Management last invest?

The most recent investment recorded for BOC & Utrust Private Equity Fund Management closed in Apr 2026. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co